Arcturus stockholders approve 3.75M share increase to equity plan, raise director compensation caps

Arcturus Therapeutics Holdings Inc.

Stockholders approved amending 2019 Omnibus Equity Incentive Plan to add 3,750,000 shares of common stock.
Annual director award limit raised from $500K to $2M for new directors, lead independent director, and non-employee chair; $1M for others.
Plan amendment passed with 9,375,429 votes for, 8,044,751 against, and 286,830 abstentions (44.7% opposed).
Directors elected, say-on-pay approved, and Ernst & Young ratified as auditor for fiscal 2022.
Stockholders voted for an annual say-on-frequency vote; Board adopted every-year frequency.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.